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ResistanceIn an earlier study, we determined that HP(2‐20) (residues 2‐20 of parental HP derived from the N-terminus of the
Helicobacter pylori ribosomal protein L1) and its analog, HPA3NT3, had potent antimicrobial effects. However,
HPA3NT3 also showed undesirable cytotoxicity against HaCaT cells. In the present study, we designed peptide ana-
logs including HPA3NT3-F1A (‐F1A), HPA3NT3-F8A (‐F8A), HPA3NT3-F1AF8A (‐F1AF8A), HPA3NT3-A1 (‐A1) and
HPA3NT3-A2 (‐A2) in an effort to investigate the effects of amino acid substitutions in reducing their hydrophobicity
or increasing their cationicity, and any resulting effects on their selectivity in their interactionswith human cells and
pathogens, as well as their mechanism of antimicrobial action.With the exception of HPA3NT3-A1, all of these pep-
tides showed potent antimicrobial activity. Moreover, substitution of Ala for Phe at positions 1 and/or 8 of the
HPA3NT3 peptides (‐F1A, -F8A and -F1AF8A) dramatically reduced their cytotoxicity. Thus the cytotoxicity of
HPA3NT3 appears to be related to its Phe residues (positions 1 and 8), which strongly interact with sphingomyelin
in the mammalian cell membrane. HPA3NT3 exerted its bactericidal effects through membrane permeabilization
mediated by pore formation. In contrast, ﬂuorescent dye leakage and nucleic acid gel retardation assays showed
that ‐A2 acted by penetrating into the cytoplasm, where it bound to nucleic acids and inhibited protein synthesis.
Notably, Staphylococcus aureus did not develop resistance to -A2 as it did with rifampin. These results suggest that
the -A2 peptide could potentially serve as an effective antibiotic agent against multidrug-resistant bacterial strains.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are small, cationic peptides that play
an important role in the innate immune system [1]. In many species,
they provide the ﬁrst line of immune defense against microbial infec-
tion [2,3]. AMPs have advantages over small-molecule antibiotics in
that they possessmultiplemodes of action, rapid kill kinetics, low levels
of resistance-inducing behavior and little host toxicity. In addition, un-
like conventional antibiotics, which have deﬁnite intracellular targets,
AMPs generally do not have speciﬁc microbial cell targets; instead,
they bind to bacterial cellmembranes and perturb themembrane struc-
ture. It is this mechanism of action that makes it unlikely that AMPsl; DMF, dimethylformamide;
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rights reserved.would induce bacterial resistance, sincemicrobeswould need to change
their entire membrane lipid composition to evade them. Consequently,
AMPs are an attractive therapeutic candidate for protection against
drug-resistant organisms.
Stomach mucosa infected with Helicobacter pylori, the bacterial
pathogen associated with gastritis and peptic ulcers, typically shows
massive inﬁltration of inﬂammatory cells and tissue destruction [4].
It has been suggested that the persistence of H. pylori within the mu-
cosa is facilitated by cecropin-like peptides with antibacterial proper-
ties, which are produced by the bacteria. Because H. pylori is resistant
to this peptide, its release gives the bacterium a competitive advan-
tage over other microorganisms [5].
The linear antimicrobial peptide HP(2‐20) is a cationic α-helical
peptide isolated from the N-terminal region of the H. pylori ribosomal
protein L1 [6]. This peptide possesses several important functional char-
acteristics: it is bactericidal, it is a neutrophil chemoattractant, and it ac-
tivates phagocyte NADPH oxidase to produce reactive oxygen species
[6]. In addition, we reported that HPA3NT3, a peptide derived from
HP(2‐20), also exerts potent antibacterial effects. The radius of the
pore in the membrane of HP(2‐20) was observed to be approximately
1.8 nm, whereas HPA3NT3, like melittin, has an apparent radius be-
tween 3.3 and 4.8 nm [7]. Unfortunately, at higher concentrations
HPA3NT3 is cytotoxic and is thus not suitable for in vivo use. Therefore,
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trations, yet retained its antibacterial activity. To that end, we designed
and synthesized a set of HPA3NT3 analogs through amino acid substitu-
tion. The antibiotic effects of the synthesized peptides were measured
against Gram-positive and Gram-negative bacteria and pathogenic fun-
gal cells. The cytotoxicity of the peptides against human red blood cells
(hRBCs), human keratinocyte cells, human cell membrane components
and sphingomyelin (SM)was also examined. Finally, themode of action
of the peptides in amodel lipid bilayer and in bacterial and fungalmem-
branes was investigated using various techniques.
2. Materials and methods
2.1. Materials
L-α-phosphatidylethanolamine (PE), sphingomyelin (SM), cho-
lesterol (CH), L-α-phosphatidyl-DL-glycerol (PG) and egg yolk L-
α-phosphatidylcholine (PC) were obtained from Avanti Polar Lipids
(Alabaster, AL). 3,3′-diethylthio-dicarbocyanine iodide (DiSC3-5),
carboxytetramethylrhodamine succinimidyl ester (TAMRA) and
calcein were from Molecular Probes (Eugene, OR). Plasmid DNA
(pTYB2) was from New England Biolabs Ltd. Erythromycin, ampicil-
lin, ciproﬂoxacin, rifampin and vancomycin were from Sigma-
Aldrich Co. All other reagents used were of analytical grade.
2.2. Microbial strains
Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 25923),
S. epidermidis (ATCC 12228) and Pseudomonas aeruginosa (ATCC
15692) were obtained from American Type Culture Collection.
Bacillus subtilis (KCTC 1998), Listeria monocytogenes (KCTC 3710),
Proteus vulgaris (KCTC 2433), Salmonella typhimurium (KCTC 1926),
Aspergillus awamori (KCTC 6915), A. parasiticus (KCTC 6598), A. ﬂavus
(KCTC 6905), A. fumigates (KCTC 6145), Candida albicans (KCTC 7270)
and Trichosporon beigellii (KCTC 7707) were from the Korean Collec-
tion for Type Cultures. E. coli CCARM 1229, E. coli CCARM 1238, S. au-
reus CCARM 3089, S. aureus CCARM 3114, Sal. typhimurium CCARM
8009 and Sal. typhimurium CCARM 8013 were from the Culture Col-
lection of Antibiotics Resistant Microbes at Seoul Women's Universi-
ty, Republic of Korea. P. aeruginosa 4007 and 3547 were resistant
strains isolated from patients in a hospital using otitis media. The
rifampin-resistant S. aureus PBEL 1 and vancomycin-resistant S. aureus
PBEL 2 used in this study were induced from normal S. aureus (ATCC
25923).
2.3. Peptide synthesis, ﬂuorescent labeling and puriﬁcation
Peptides were synthesized using 9-ﬂuorenylmethoxycarbonyl
(Fmoc) solid-phasemethods on Rink amide 4-methyl benzhydrylamine
resin (Novabiochem) (0.55 mmol/g) and a Liberty microwave peptide
synthesizer (CEM Co. Matthews, NC). To generate N-terminal ﬂuores-
cently labeled peptides, resin-bound peptides were treated with 20%
(v/v) piperidine in dimethylformamide (DMF) to remove the Fmoc
protecting group from theN-terminal amino acid. The resin-boundpep-
tide was then reacted with rhodamine-SE in DMF (3–4 eq.) containing
5% (v/v) diisopropylethylamine. After gently mixing for 24 h in the
dark, the resins were washed thoroughly, ﬁrst with DMF and then
with dichloromethane (DCM). The peptides were cleaved from their re-
spective resins, precipitated with ether, and extracted [8,9]. The crude
peptides were puriﬁed using reversed-phase preparative HPLC on a
Jupiter C18 column (250×21.2 mm, 15 μm, 300 Å) with an appropriate
0–60% acetonitrile gradient in water containing 0.05% triﬂuoroacetic
acid. The purity of the peptide was then determined by analytical
reversed-phase HPLC using a Jupiter Proteo C18 column (250×4.6 mm,
90 Å, 4 μm). The molecular masses of the peptides were conﬁrmedusing matrix-assisted laser desorption ionization mass spectrometry
(MALDI II, Kratos Analytical Ins.) [7].
2.4. Antibacterial activity
Bacterial cells were cultured at 37 °C in appropriate culture media,
and the antimicrobial activity of each peptide was determined in
microdilution assays. Brieﬂy, two-fold serial dilutions covering a
range from 0.25 to 128 μM for each peptide were added to duplicate
media containing cultures of test bacteria (5×105 CFUs/ml) at their
mid-logarithmic phase of growth. The samples were then incubated
for 18–24 h at 37 °C. At the end of the incubation, minimum inhibito-
ry concentrations (MICs) of the peptides were determined by evalu-
ating growth based on the OD600 of the cultures. MICs were deﬁned
as the lowest peptide concentrations that completely inhibited bacte-
rial growth [7].
2.5. Antifungal activity
In order to evaluate the activity of the peptides against various fun-
gal pathogens, spores from 10-day-old cultures grown on PDA (potato
dextrose agar) plates at 28 °C were collected using 0.08% Triton
X-100. The spores were then suspended in a medium containing half
10 mMMES buffer and half YPD (yeast peptone dextrose media: yeast
extract 0.5%, peptone 1% and dextrose 2% at pH 5.0–5.5), and then incu-
bated overnight. Eighty μL of the spore suspension (ﬁnal concentration
of 104 spores/ml) in PD (potato dextrose)mediawas added to thewells
of a 96-well microtiter plate, afterwhich 20 μL of two-fold serially dilut-
ed peptide solution in 10 mMMES buffer (pH 6.0) containing YPDor PD
media was added to the wells. After 24 to 36 h of incubation at 28 °C,
inhibition of fungal growth or germination was evaluated visually
using an inverted microscope, and by assessing the turbidity of each
well by measuring the absorbance at 595 nm using a microtiter reader
[10].
2.6. Hemolysis
Fresh hRBCs from healthy donors were centrifuged at 800×g and
washed with PBS until the supernatant was clear. Two-fold serial di-
lutions of peptide in PBS were added to the wells of a 96-well plate
plated, after which hRBCs were added to a ﬁnal concentration of 8%
(v/v). The samples were then incubated with mild agitation for 1 h
at 37 °C. After then centrifuging the samples at 800×g for 10 min,
the absorbance of the supernatant was measured at 414 nm. All mea-
surements were made in triplicate [11,12], and the percent hemolysis
was calculated using Eq. (1):
% hemolysis ¼ Abs414 in the peptide solution−Abs414 inPBSð Þ=
Abs414 in 0:1% Triton−X100−Abs414 in PBSð Þ  100
ð1Þ
where, 100% hemolysis was deﬁned as the absorbance measured
from hRBCs exposed to 1% Triton X-100, and zero hemolysis was
characterized with hRBCs alone in PBS.
2.7. Cell culture and cytotoxicity
To examine the cytotoxic effects of the peptides, HaCaT (cultured
human keratinocyte) cells were cultured in Dulbecco's modiﬁed Eagle
medium (DMEM) supplemented with antibiotics (100 U/ml penicillin,
100 μg/ml streptomycin) and 10% fetal calf serum at 37 °C in a humid-
iﬁed chamber under an atmosphere containing 5% CO2. Growth inhibi-
tion was evaluated using MTT assays to assess cell viability. A total of
4×103 cells/well was seeded onto a 96-well plate and incubated for
24 h. Two-fold serial dilutions of peptides in DMEM were then added
to the plate and incubated for 24 h at 37 °C, after which 10 μL of
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4 h. The supernatants were then aspirated, and 50 μl of DMSO was
added to the wells to dissolve any remaining precipitate. Absorbance
at 570 nm was then measured using a microtiter reader [10,12].
2.8. Peptide-evoked membrane depolarization
E. coli were grown to mid-log phase at 37 °C with agitation, after
which they were washed once in buffer A (20 mM glucose, 5 mM
HEPES, pH7.3) and resuspended to anOD600 of 0.05 in buffer A containing
0.1 M KCl. The cells were then incubated with 1 μM DiSC3-5 until stable
baseline ﬂuorescence was achieved. Peptides were then added to 480 μl
of the bacterial suspension, afterwhich changes inﬂuorescencewere con-
tinuously recorded (excitation wavelength, 622 nm; emission wave-
length, 670 nm) for 30 min [7].
2.9. Time-kill kinetics of the peptides
The bactericidal kinetics of the peptides was assessed for compar-
ison with the membrane depolarization activity. Suspensions of E. coli
(OD600=0.05) were added to peptide solutions at the same concen-
trations used in the membrane depolarization experiment. Bacteria
were then sampled after 0, 2, 4, 6, 8, 10, 15, 20, 30, 40 and 60 min
of exposure to the peptides. The sampled bacteria were then diluted
20-fold and plated on Luria broth agar. After incubation overnight,
the colonies were counted [13].
2.10. SYTOX green uptake
E. coli cells were grown to mid-logarithmic phase at 37 °C, washed,
and suspended (2×107 cells/ml) in 10 mM sodium phosphate buffer
(pH 7.2). The cells were then incubated with 1 μM SYTOX green for
15 min in the dark [14]. After the addition of peptides at the appropriate
concentrations, the time-dependent increases in ﬂuorescence caused
by the binding of the cationic dye to intracellular DNA were monitored
(excitation wavelength, 485 nm; emission wavelength, 520 nm).
2.11. Confocal laser-scanning microscopy
To analyze the cellular distribution of the peptides, E. coli and
C. albicans were incubated in the presence of tetramethyl rhodamine
(TAMRA)-labeled peptide and observed on a confocal laser-scanning
microscope. The cells were inoculated and adjusted following the pro-
cedure used for the antimicrobial assay. TAMRA‐labeled peptides at
their respective MICs were added to 100 μl of the cell suspension.
After incubation for 30 min, the cells were pelleted by centrifugation
at 4000 rpm for 5 min andwashed three timeswith ice-cold PBS buffer.
Localization of the TAMRA-labeled peptides was then examined using
an inverted LSM510 laser-scanning microscope (Carl Zeiss, Gőttingen,
Germany) equipped with helium/neon laser (543 nm line). The
resulting images were recorded digitally in a 512×512 pixel format
[15].
2.12. Preparation of liposomes and measurement of calcein leakage
Small and large unilamellar vesicles (SUVs and LUVs) were pre-
pared using the sonication and freeze-thaw methods, respectively
[16,17]. The desired mixtures of lipids were dissolved in chloroform,
dried in a glass tube under nitrogen, and then lyophilized overnight
to remove residual solvent. The dry lipid ﬁlms were resuspended in
1–2 ml of appropriate buffer in a water-bath for 30 min at 50 °C,
and the resulting mixtures were vortexed. To prepare the SUVs, the
lipid dispersions were sonicated in a bath-type sonicator for 30 min
until the turbidity had cleared. LUVs were prepared using eight
freeze-thaw cycles under liquid nitrogen in a water bath at 50 °C.
To ensure a homogeneous population of vesicles, after theirpreparation, the suspensions were extruded 15 times through poly-
carbonate membranes with 0.05 and 0.2 μm diameter pores for
SUVs and LUVs, respectively. Their concentrations were determined
using a standard phosphate assay [18]. The average diameters of the
vesicles were conﬁrmed using transmission electron microscopy
(FEI Tecnai 12).
The ability of the peptides to permeabilize liposomeswas assayed by
measuring calcein leakage. Liposomeswith entrapped calceinwere pre-
pared as described previously. In brief, the dried lipid was hydrated
with dye buffer solution (80 mM calcein, 10 mM HEPES, 30 mM NaCl,
pH 7.4), vortexed for 1 min and incubated for 30 min at 50 °C. The
suspension was then subjected to nine cycles of freeze-thaw in liquid
nitrogen to create LUVs, and then extruded 30 times through polycar-
bonate ﬁlters (two stacked 0.2-μm pore size ﬁlters) using an Avanti
Mini-Extruder (Avanti Polar Lipids Inc., Alabaster, AL). The calcein-
containing LUVs were separated from the free calcein by gel ﬁltration
chromatography on a Sephadex G-50 column, after which suspensions
containing 2.5 μM lipid were incubated with various concentrations of
peptide. The ﬂuorescence of the released calcein was measured using
a spectroﬂuorometer (Perkin-Elmer LS55) at an excitation wavelength
of 480 nm and an emission wavelength of 520 nm. Complete (100%)
release of calcein was achieved by adding Triton X-100 to a ﬁnal con-
centration of 0.03% (w/v). Spontaneous leakage was determined to be
negligible in the time-frame of this experiment. The experiments
were conducted at 25 °C. The apparent percent calcein release was cal-
culated using Eq. (2) [7,19]:
Release %ð Þ ¼ 100 F−F0ð Þ= Ft−F0ð Þ ð2Þ
2.13. Tryptophan ﬂuorescence blue shift
The ﬂuorescence emission spectrum of the Trp residues in the
peptides was monitored in aqueous buffer and in SUVs composed of
PE/PG (7:3, w/w), PC/SM (2:1, w/w) or PC/CH (2:1, w/w). Aliquots
of 2 μM peptide solution were added to 1 ml of 10 mM HEPES (pH
7.2), or to vesicles at a total lipid concentration in the range from
0 to 300 μM. Trp ﬂuorescence was then excited at 280 nm, and the
emission spectrumwas measured from 300 to 450 nm in 1-nm incre-
ments with 1-s signal averaging. The wavelength with the maximum
ﬂuorescence emission was then plotted against the lipid concentra-
tion. Trp ﬂuorescence measurements were made using a Perkin-
Elmer LS55 ﬂuorometer.
2.14. DNA/RNA gel retardation assay
Plasmid pTYB 2 (NEB Ltd.) was puriﬁed using a plasmid extraction
kit (Exprep™ Quick, GeneAll Biotechnology Co., Seoul, Republic of
Korea), while yeast RNAwas isolated using TRI reagent (MRC Inc. Cin-
cinnati, OH). The resulting plasmid DNA (200 ng) or yeast RNA
(10 μg) was mixed with increasing amounts of peptide in buffer
containing 10 mM Tris (pH 8.0), 1 mM EDTA, 5% glycerol, 20 mM
KCl and 50 μg/ml BSA. The mixtures were incubated for 10 min at
37 °C and then subjected to electrophoresis on a 0.5 or 1% agarose
gel in TBE buffer, followed by ethidium bromide staining [20]. Gel re-
tardation was visualized under UV illumination using a Bio-Rad Gel
Documentation system (UK).
2.15. Transmission electron microscopy
The pTYB2 DNA was expressed in E. coli cells grown to mid-log
phase at 37 °C. The cells were then suspended in 10 mM sodium
phosphate buffer to achieve an OD600 of 0.15. They were then sonicat-
ed and centrifuged in order to collect the pTYB2 DNA. The pTYB2 DNA
was then negatively stained with 1% (w/v) uranyl acetate (UAC) in
the absence or presence of -A2. The DNA was visualized using a FEI
Fig. 1. Helical wheel diagram of HPA3NT3 and its analogs. The analogs were produced through amino acid substitution, as indicated.
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ﬁcations of 67,000×(for OsmC), 52,000×(for Lon, CodWX and SOX)
or 40,000×(for ClpB), and using an acceleration voltage of 120 kV
and a magniﬁcation of 21 K and 52 K, as described [21].
2.16. Inhibition of expression of recombinant green ﬂuorescent protein
(GFP) in E. coli
E. coli BL21 (DE3) cells transfected with pET28a-GFP were grown
to mid-log phase at 37 °C. After which aliquots were suspended in
10 mM sodium phosphate buffer containing 10% LB media to an
OD600 of 0.15. Peptides at 1/4-MIC, 1/2-MIC or MIC were added to
the mixtures, which were then incubated for 30 min. Thereafter,
0.5 mM of IPTG was added to induce GFP expression, and the mixture
was incubated for 4 h at 37 °C. The cells were then centrifuged and
washed three times to remove unreacted peptide, lysed by sonication
and centrifuged again. The cytosolic proteins in the supernatant were
then visualized using ﬂuorescence microscopy or 15% SDS-PAGE.
2.17. Resistance development
A single colony of S. aureus ATCC 25923 was cultured at 37 °C in
appropriate culture media to determine the MICs of the two peptides
(LL-37 and -A2), and rifampin and vancomycin, as described above.
The ﬁnal concentrations of the peptides ranged from 256 to
0.125 μM, while those of rifampin and vancomycin ranged from 156Table 1
Amino acid sequences, retention times, and mean hydrophobicities (H) of HPA3NT3 and it
Name Sequence Remarks
HPA3NT3 FKRLKKLFKKIWNWK-NH2 Parent peptide
-F1A AKRLKKLFKKIWNWK-NH2 HPA3NT3: F1→ A1
-F8A FKRLKKLAKKIWNWK-NH2 HPA3NT3: F8→ A8
-F1AF8A AKRLKKLAKKIWNWK-NH2 HPA3NT3: F1,F8→ A1,A8
-A1 AKRLKKLAKKIWKWL-NH2 -F1AF8A: N13,K15→ K13,L15
-A2 AKRLKKLAKKIWKWK-NH2 -F1AF8A: N13→ K13
a Mean retention times (min) analyzed by RP-HPLC.
b Mean hydrophobicity (H) and mean relative hydrophobic moments (μH) were calculat
HydroMCalc.html).
c Hemolysis and
d cytotoxicity were assayed against hRBCs and HaCaT cells, respectively, at a peptide conto 0.00119 μM and from 88.3 to 0.043 μM, respectively. Daily MICs
were determined for 15 days for each agent using cells from the
well containing one-half the MIC (1/2 MIC well). In brief, cells from
the 1/2 MIC well were suspended in appropriate culture media and
incubated overnight at 37 °C, after which the suspensions were ad-
justed to 5×105 CFU/ml in DMEM supplemented with 10% FBS and
mixed with agents in the same concentration ranges. All MICs were
determined in duplicate [22].
3. Results
3.1. Design and antimicrobial/cytotoxic activities of HPA3NT3 analogs
HPA3NT3 has an amphipathic helical structure, as indicated by the
helical wheel diagram in Fig. 1. The Phe residues at positions 1 and
8 are situated at the hydrophobic face and are crowding the Trp res-
idue at position 12. From this starting point, we designed analog pep-
tides using three approaches: (1) reduce the hydrophobicity by
replacing Phe with Ala, (2) increase the cationicity by replacing Asn
with Lys, and (3) create completely amphipathic divisions in the
helical wheel diagram by replacing Asn with Lys in position 13 and
Leu with Lys in position 15. The sequences of the peptides are
shown in Table 1. We then investigated the antimicrobial activities
of the peptides against eight pathogenic bacteria and six fungal
strains (Table 2). To evaluate cell selectivity, we determined the he-
molytic and cytotoxic activities of the peptides against hRBCs ands analogs.
Retention
timea
Hb Hemolysis
(%)c
Cytotoxicity
(%)d
20.94 −0.60 69.2 85.1
19.45 −1.34 7.1 68.3
17.93 −1.34 4.6 60.1
16.25 −2.08 0 7.8
19.87 −0.96 20.9 78.7
15.20 −2.26 0 11.7
ed to CSS scale using HydroMCalc (http://www.bbcm.univ.trieste.it/~tossi/HydroCalc/
centration of 250 μM.
Table 2
Antimicrobial activity of HPA3NT3 and its analogs against various pathogens.
Microorganism MICs (μM)
1⁎ 2⁎ 3⁎ 4⁎ 5⁎ 6⁎
Gram (−) bacteria
E. coli 4 4 4 32 32 4
P. aeruginosa 2 1 2 2 32 2
P. vulgaris 8 4 4 4 8–16 2–4
S. typhimurium 2 1 2 2 8 1–2
Gram (+) bacteria
S. aureus 2 2 4 16 16 4
L. monocytogenes 2 2 2 2 16 2
S. epidermidis 2–4 2–4 2–4 16 8 2–4
B. subtilis 2 2 4 4 8 2
Yeast
C. albicans 8 8 8 16 16 8
T. beigelii 16 16 16 32 >128 16
Fungi
A. awamori 16 16 16 16 64 8
A. ﬂavus 16 16 16 32 64 8
A. fumigatus 4 8 8 4 16 4
A. parasiticus 8 8 8 8 16 8
⁎ 1, 2, 3, 4, 5 and 6 indicate HPA3NT3, -F1A, -F8A, -F1AF8A, -A1 and -A2, respectively.
All assayswere performed in a 10 mM sodiumphosphate (pH 7.2) containing 10% culture
media.
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microbial activities of the single substitutes (‐F1A and -F8A) were
close to or slightly greater than that of HPA3NT3, and their cytotoxic
activities were somewhat lower. The -F1AF8A double substitute was
considerably less hemolytic than the single substitutes, and its MIC
against the various microbes was similar to or less than that of
HPA3NT3 (Table 2). In contrast, -A2 showed greater antimicrobial ac-
tivity than -F1AF8A or HPA3NT3 against some of the microbes testedFig. 2.Membrane binding and dye release with artiﬁcial zwitterionic vesicles. Emission maxi
C) and peptide induced calcein leakage from LUVs (B and D). Data in A and B were obtaine(Table 2). Furthermore, -A2 exhibited no hemolytic activity, even at
250 μM (Table 1), nor did it show signiﬁcant cytotoxicity against
HaCaT cells (Table 1). Of the several analogs synthesized, only the
mechanism of action of -A2 was studied in detail, since it had the
highest antimicrobial activity with the least cytotoxicity.3.2. Membrane binding and dye release with artiﬁcial
zwitterionic vesicles
To determine how the hemolytic and cytotoxic activities of HPA3NT3
were ameliorated in ‐F1AF8A, binding and permeabilization activity was
assessed based on Trp ﬂuorescence and calcein leakage using artiﬁcial,
PC/CH (2:1, w/w) and PC/SM (2:1, w/w) LUVS. PC, CH and SM are
common lipids found in the mammalian erythrocyte membrane.
HPA3NT3, ‐F1A, -F1AF8A and -A1 did not bind to PC/CH vesicles, and
there was no signiﬁcant calcein leakage from those vesicles (Fig. 2A
and B). In contrast, HPA3NT3 strongly bound to PC/SM vesicles, resulting
in a shift in the Trp ﬂuorescence maximum from 351.5 to 339 nm in the
presence of 300 μM vesicles (peptide/lipid molar ratio, 1:150) (Fig. 2C).
Moreover, HPA3NT3 induced a corresponding loss of calcein from the
PC/SM vesicles (Fig. 2D) -F1A and -F1AF8A did not bind to the PC/SM
LUVs and thus did not induce calcein leakage. However, Fig. 2C and D
shows that treatment with -A1 shifted the Trp ﬂuorescence maximum
and caused a 40% loss of calcein from PC/SM vesicles, a result reﬂecting
its greater hydrophobicity. In 10 mM HEPES buffer (pH 7.2), HPA3NT3,
-F1A and -F1AF8A exhibited ﬂuorescence emission maxima at 351 nm,
which corroborates the earlier ﬁnding that Trp residues in these peptides
are located in a hydrophilic environment. However, when lipid vesicles
were present, as the Trp residues in ‐A1 moved to a less polar environ-
ment the emission maximum shifted to 349 nm. This observation
could explain the apparent cytotoxicity of -A1, but we do not have thema from Trp in peptides in the presence of the indicated concentrations or LUVs (A and
d with PC/CH (2:1, w/w) vesicles, those in C and D with PC/SM (2:1, w/w) vesicles.
Fig. 3. Blue shift in Trp ﬂuorescence and calcein release from PE:PG liposomes. Emission maxima from Trp in peptides in the presence of PE/PG LUVs (A) and calcein leakage from
the vesicles (B).
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to provide a conclusive determination.3.3. Blue shift in Trp ﬂuorescence and calcein release from
PE:PG liposomes
The actions of the peptides towards PE:PG (7:3, w/w) LUVs, which
mimic a bacterial membrane, were determined using Trp blue shift
assays and calcein leakage assays. The degree to which the peptides
interacted with the membrane (1:25 peptide-to-lipid ratio) was in
the order, HPA3NT3>-A2>-F1AF8A>-A1 (Fig. 3A). The largest blue
shift was seen with HPA3NT3, which suggests the Trp side chain
partitioned preferentially into a more rigid, hydrophobic environ-
ment in the PE:PG LUVs [23]. Treating PE:PG LUVs with HPA3NT3 at
a 1:10 P/L molar ratio resulted in a maximum leakage of 100%,Fig. 4. Confocal laser scanning micrograph images of E. coli cells treated with TAMRA-
TAMRA-labeled peptide for 10 min at 37 °C in PBS (pH 7.2). From left to right: TAMRA, difwhereas -A2 released a maximum of approximately 32% of the
entrapped calcein (Fig. 3B).
3.4. Intermembrane and intracellular localization of the peptides
The morphology of E. coli cells incubated in the presence of the pep-
tides was examined using light microscopy during the antimicrobial
assay. Whereas untreated cells tended to gather together (data not
shown), cells treated with HPA3NT3 were scattered (data not shown).
HPA3NT3 reduced the bacterial population at the 1/2-MIC, yet the
cells retained a shape similar to normal E. coli. Interestingly, in the pres-
ence of -A2 the cells appeared to be elongated in shape (data not
shown), a result suggesting that cell divisionwas inhibited. The location
of ﬂuorescently labeled peptide in both of the treated E. coli cultures
was monitored using confocal laser scanning microscopy. TAMRA-
HPA3NT3 (at itsMIC) accumulated to a greater degree at the cell surfacelabeled- TAMRA-HPA3NT3 (a) or TAMRA-A2 (b). The cells were treated with MIC
ferential interference contrast (DIC), merged images.
Fig. 5. Kill kinetics and membrane permeation. Time-kill kinetic (A), time-dependent depolarization (B) and inﬂux of SYTOX green (C and D) in E. coli. A, E. coli cells were exposed
to peptides at 1x or 2x MIC, and incubated for 0–100 min. Data were recorded at 5-min intervals. B, E. coli cells in mid-logarithmic phase were adjusted to OD600=0.05
and pre-equilibrated for 60 min with diS-C35. HPA3NT3 (solid line) or -A2 (dotted line) was then added to 4 μM, and changes in ﬂuorescence were monitored continuously
(Ex. 622 nm and Em. 670 nm) and plotted as arbitrary units. The second arrow indicates the addition of Triton X-100 (0.1%) to conﬁrm the maximum depolarization. C and D,
E. coli (2×107 cells/ml) were incubated with 1 μM SYTOX green for 15 min. HPA3NT3 (C) or -A2 (D) were added when the basal ﬂuorescence reached a steady value, and the in-
crease of ﬂuorescence was recorded at the indicated times (Ex. 485 nm and Em. 520 nm).
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(Fig. 4). This suggests that -A2 was translocated to the cytoplasm
where it potentially interacted with DNA, RNA and related proteins.
3.5. Kill kinetics and membrane permeation
Fig. 5A shows time-kill curves for HPA3NT3 and -A2 against E. coli at
1x and 2x MIC. The kill kinetics for HPA3NT3 were faster than for -A2;
moreover, HPA3NT3 killed 100% of the bacterial cells while -A2 achieved
only partial elimination of the bacteria. To evaluate peptide-induced
membrane permeabilization, we assessed the ability of the peptides to
induce membrane depolarization in E. coli. HPA3NT3 maximally
depolarized E. coli cells at 4 μM but -A2 elicited only half the maximum
at the same concentration, even though both peptides had the same
MIC (Fig. 5B). This result suggests that these peptides interact with the
E. coli membrane differently, which in turn suggests the mechanisms
that their antimicrobial actions also likely differ. We monitored the pep-
tides' permeabilization of E. colimembranes by measuring the uptake of
the normally impermeant nucleic acid binding molecule, SYTOX green
(Fig. 5C and D). The results indicated that HPA3NT3 induces greater up-
take of the dye than does -A2. The rate of permeabilization was partially
concentration-dependent and increased with increasing concentrations
of HPA3NT3 up to 8 μM. At concentrations above 8 μM there was no
change in the kinetics of SYTOX green uptake, a result suggesting that
permeabilization by HPA3NT3 is saturable. The maximum uptake of-A2 occurred at 1/2-MIC (2 μM) and there was no change in the perme-
abilization at higher concentrations (4, 8 and 16 μM).3.6. Peptide binding to DNA and RNA
We next examined peptide binding to plasmid DNA and yeast
RNA. The peptides were mixed with a ﬁxed amount of plasmid
(pTYB2) DNA (pDNA) (Fig. 6A) or yeast RNA (Fig. 6B), after which
the samples were electrophoresed on agarose gels. The -A2 complete-
ly retarded pDNA migration at a peptide/pDNA weight ratio of 0.5
(Fig. 6A, bottom of the right panel). When treated with indolicidin,
which is known to bind to pDNA at a ratio of 1 (Fig. 6A, top of the
right panel) [24], complete retardation of the DNA migration was ob-
served. In contrast, magainin-II did not affect the pDNA migration,
even at a peptide/pDNA weight ratio of 4, indicating that magainin-II
had no interaction with the pDNA (Fig. 6A, top of the left panel). In ad-
dition, Fig. 6B shows that the binding of -A2 to yeast RNA was greater
than that observed with buforin 2. RNA binding was observed, even at
low peptide concentrations, as indicated by the slight downward shift
in the RNA band. In order to conﬁrm the -A2 binding to pTYB2, the pep-
tide and the plasmid were mixed together and then examined using
transmission electron microscopy. Fig. 6C shows that the pTYB2 DNA
did not aggregate in the absence of peptide (Fig. 6C, left panel). On
the other hand, the pTYB2 DNA clumped together in the presence of
Fig. 6. Peptide binding to DNA and RNA. Gel retardation analysis of peptides binding to DNA (A) and RNA (B) and negative staining of the DNA-peptide complex (C). A and B, Bind-
ing was assayed based on the inhibitory effect of the peptides on the migration of DNA or RNA. The indicated amounts of peptide were mixed with 200 ng of plasmid DNA (pTYB 2,
A) or 10 μg of yeast RNA (B) and incubated for 10 min at 37 °C. The reaction mixtures were then applied to a 1% (A) or 0.5% (B) agarose electrophoresis gel. C, pTYB2 DNA in the
absence or presence of -A2 was negatively stained with 1% UAC and visualized using transmission electron microscopy. Values at the top are peptide to DNA or RNA ratios.
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and pTYB2 DNA.
3.7. Inhibition of recombinant GFP expression in E. coli
To investigate the effect of intracellular -A2 on GFP expression in
E. coli cells, expressed GFP was visualized using either ﬂuorescent mi-
croscopy or 15% SDS-PAGE. Fig. 7A shows that untreated cells pro-
duced strong ﬂuorescence, but that the ﬂuorescence declined when
the cells were exposed to increasing concentrations of -A2. In addi-
tion, when we used SDS‐PAGE to assess GFP expression in E. coli in
the presence and absence of the peptide, we found that GFP expres-
sion gradually declined with increasing concentrations of -A2 until,
at 1x MIC, the GFP band was completely absent (Fig. 7B). This result
suggested that -A2 enters E. coli cells, binds to nucleic acids, and in-
hibits protein synthesis.
3.8. -A2 does not induce resistance, in vitro
The development of resistance to -A2, and to rifampin and vancomy-
cin (positive controls), was evaluated using S. aureus (ATCC 25923,
antibiotic-susceptible strain) after its growth in the presence of the re-
spective antibiotics. TheMIC for rifampin, which is known to quickly in-
duce resistance through chromosomal pointmutation [25], signiﬁcantlyincreased 8192-fold over the course of 12 passages. In contrast, theMIC
for vancomycin increased only 4-fold, and there was no change in the
MIC for -A2. Thus, unlike rifampin, exposure to -A2 did not lead to the
development of resistance in S. aureus (Fig. 8). We also assessed the
bactericidal activity of -A2 against various other antibiotic- and
multidrug‐resistant strains. The results are summarized in Table 3.
4. Discussion
Because AMPs mainly interact with lipid membranes through elec-
trostatic and hydrophobic interactions, the structure and function of
the transmembrane domain of membrane proteins have been used to
characterize and evaluate the mechanisms of action of antimicrobial
peptides atmembrane-water interfaces and in lipid bilayers. The explo-
ration of these mechanisms has led to the development of models in-
cluding the barrel-stave model [26,27], toroidal pore formation [28],
detergent-like model [29] and the translocation model [30]. Studies of
transmembrane proteins/AMPs have suggested that the indole side
chain of Trp is ideally suited for interacting with the polar–nonpolar in-
terface, with the highly hydrophobic aromatic ring preferentially buried
in the hydrophobic region of the lipid bilayer [31]. Hydrophobic Phe res-
idues also contain an aromatic ring, which mainly situates in the trans-
membrane portion of membrane proteins or in the hydrophobic region
of the lipid bilayer [32]. This clearly suggests that Phe and Trp have
Fig. 7. Inhibition of recombinant GFP expression in E. coli. Inhibition of GFP expression by -A2. A, After incubation for 30 min in the presence of the indicated concentration of -A2,
E. coli BL21(DE3) cells transfected with pET28(a)-GFP were exposed to 0.5 mM IPTG for 2 h to induce GFP expression: a, phase-contrast images of the cells; b, GFP ﬂuorescence from
the same cells. B, SDS-PAGE analysis of total soluble protein collected from GFP-expressing cells incubated in the absence or presence of peptide.
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semblemammalianmembranes. In addition, positively charged Lys and
Arg residues have relatively long aliphatic side chains that prefer the
polar region of the negatively charged phosphate groups in microbial
membranes [31,33,34]. Thus, amino acid side chains play a key role in
the antimicrobial and cytotoxic activities of AMPs, as well as determin-
ing their selectivity formicrobial andmammalianmembranes [35]. This
ﬁnding suggests that synthetic AMPs could be speciﬁcally designed in
order to interact with speciﬁc targets of the microbial cell wall (sur-
rounding the cytoplasmic membrane), based on their amino acid com-
bination, charge and hydrophobicity/hydrophilicity [36,37].
With this in mind, we designed several analogs from the parent
peptide, HPA3NT3, which is a truncated analog of HP(2‐20) derived
from the N-terminus of the Helicobactor pylori ribosomal protein L1
[7]. Through a pore-forming mechanism, HPA3NT3 exerts potent an-
timicrobial effects against an even broader spectrum of microbes than
does HP(2‐20) [11]. Unfortunately, HPA3NT3 cannot be utilized in
vivo due to its cytolytic activity at efﬁcacious dose concentrations.
We suggest that the binding of HPA3NT3 to the plasma membrane
is mediated by the hydrophilic face, and that the inserts into the hy-
drophobic face of the bilayer due to the presence of two Trp residues
at that end. If this is so, how does HPA3NT3 recognize the mammalianplasma membrane? We propose that recognition is via the aromatic
rings of Phe and Trp, which are packed on the hydrophobic face of
the amphipathic helical structure (Fig. 1) and are known to interact
with CH and SM in order to exert its hemolytic and cytolytic effects
[7]. In addition, the strong hydrophobicity of HPA3NT3 may enable
its insertion into the lipid interior of the mammalian membrane
which is mainly composed of zwitterionic lipids.
In our analysis, Trp was never substituted because it is conserved
in all natural AMPs and is essential for their antibacterial activity; its
indole side chain strongly interacts with bacterial phospholipid mem-
branes, thereby promoting toxicity [38], so that replacing Trp with
another amino acid diminishes an AMP's antimicrobial activity [39].
Instead, HPA3NT3 analogs were produced by substituting one or
both of the Phe residues (position 1 and/or 8) with an Ala residue
to reduce the peptide's hydrophobicity. As shown in Table 1, the re-
tention times and hydrophobicity of -F1A, -F8A and -F1AF8A were
lower than those of HPA3NT3. The hydrophobicity (H), net charge
and hydrophobicmoment are three important physicochemical param-
eters useful when evaluating membrane-interfacial and pore-forming
AMPs andmembrane proteins [11,39]. The bacterial plasmamembrane
consists mainly of zwitterionic PE combined with a large amount of an-
ionic lipids, such as PG and cardiolipin, whereas the membrane of
Fig. 8. -A2 does not induce resistance in vitro. Induction of resistance to antimicrobial
peptides and conventional antibiotics. The Y-axis indicates the relative change in the
MIC from the ﬁrst passage.
Table 3
Antibacterial activity of HPA3NT3 and -A2 against drug-resistant strains.
Strains MIC (μM)
HPA3NT3 -A2 Erya Ampa Cipa
E. coli CCARM 1229§ 2 1 – >512 512
E. coli CCARM 1238§ 2 2 – >512 512
P. aeruginosa 3547¶ 4 2 – – 256
P. aeruginosa 4007¶ 1 1 – – 256
S. aureus CCARM 3089§ 2 2 >512 – –
S. aureus CCARM 3114§ 4 4 >512 – –
S. aureus PBEL 1⁎ 1 1 – – –
S. aureus PBEL 2⁎ 1 1 – – –
S. typhimurium CCARM 8009§ 4 1 – >512 –
S. typhimurium CCARM 8013§ 1 1 – >512 –
§ These strains (with CCARM numbers) were obtained from the Culture Collection of
Antimicrobial Resistant Microbes, in Korea.
¶ These resistant strains were isolated from patients in a hospital using otitis media.
⁎ S. aureus PBEL 1 and 2 were, respectively, rifampin-resistant and
vancomycin-resistant strains induced in this study. All peptides were assayed in DMEM
supplemented with 10% FBS. Ery, Amp and Cip are erythromycin, ampicillin and cipro-
ﬂoxacin, respectively.
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consists almost exclusively of the zwitterionic phospholipids PC and
sphingomyelin, as well as cholesterol. Substituting Ala for Phe in -F1A,
-F8A and -F1AF8A clearly diminished their cytotoxicity in association
with reduced hydrophobicity and altered hydrophobic moment. In par-
ticular, Phe residues have a strong afﬁnity for SM, and the analog pep-
tides showed less binding to and permeabilization of PC/SM vesicles.
This probably reﬂects the absence of the Phe aromatic rings, which are
closely packed at the same face of HPA3NT3 (Fig. 1), and are required
for insertion of the peptide into SM-containing membranes. On the
other hand, none of the tested peptides effectively bound to PC/CH ves-
icles.Moreover, our results indicate that the hemolytic and cytotoxic ac-
tivities of these peptides were directly related to the SM content in the
outer leaﬂets of hRBCs and HaCaT cells.
The amino acids were substituted while maintaining the amphi-
pathic organization of the HPA3NT3 peptide (Fig. 1). Augmentation
of the hydrophobicity of the peptides through substitution of Lys
and Leu for Asn and Lys at positions 13 and 15 of -F1AF8A (‐A1) dra-
matically increased hemolysis and cytotoxicity. This suggests that the
hydrophobicity is a key determinant of the hemolytic and cytotoxic
properties of an AMP [7] (Table 1).
Another peptide analog was designed to increase the net positive
charge by substituting Lys for Leu at position 15 without changing the
Lys residue at position 13 (‐A2). The Lys residue at position 13 of -A1
was left unchanged because it was previously shown that positive
charge substitution did not affect the α‐helical structure or cytotoxic
activity [40], but the hydrophobic Leu residue at position 15 of -A1
had critical effects on its cytotoxicity [7] (Table 1, Fig. 2) and
antibacterial activity [41] (Tables 2 and 3, Fig. 3).
AMPs generally kill bacteria through permeabilization of the cyto-
plasmic membrane or by binding to intracellular targets, such as
nucleic acids [1]. It is reasonable to assume that AMPs containing
HPA3NT3-like motifs interact with and damage the cytoplasmic
membrane, and do not bind to nucleic acids [11]. However a substitu-
tion at position 13 appears to change the mechanism of action
(Fig. 3). The bactericidal activity of -A2 was conﬁrmed usingE. coli-based assays designed to evaluate its killing kinetics, which
showed that cell viability reduced signiﬁcantly within 40 min of
treatment. In addition, HPA3NT3 and -A2 had the same MIC as
E. coli, but the killing kinetics of -A2 was slower than those for
HPA3NT3, a ﬁnding which suggested that a different mechanism con-
tributes to -A2 killing action (Fig. 5A). The antimicrobial action of
some AMPs involved their insertion into the cytoplasmic membrane,
pore formation, and resultant dissipation of the membrane potential
and disruption of lipid asymmetry [26–30]. We examined the interac-
tion of -A2 with the membrane using bacterial cells. We found that
-A2 completely dissipated the membrane potential of E. coli at its
MIC, whereas HPA3NT3 induced minimal depolarization (Fig. 5B).
The -A2 also induced increasing efﬂux of SYTOX green (Fig. 5C and
D), concentration-dependently, indicating that it effected both the
outer and inner membrane. This notion was supported by the ﬁnding
that TAMRA-A2 localized mainly in the membrane or cytoplasm of
E. coli, depending upon its concentration. This result suggested that
-A2's bactericidal activity reﬂects both an action at the membrane
and an intracellular action in the cytoplasm (Fig. 4).
Interestingly, in this study we found that -A2 peptide entering the
cytoplasm through self-formed pores speciﬁcally bound to DNA
(Fig. 6A and C) or RNA (Fig. 6B), a ﬁnding which is expected to inhibit
protein synthesis (Fig. 7B). This hypothesis of its mechanism of action
explains its favorable killing kinetics and the increased efﬂux of
SYTOX green over the MIC value.
It is noteworthy that the mechanism by which -A2 penetrated
the bacterial cell membrane relied on the substitution of the amino
acids at positions 1, 8 and 13 of HPA3NT3. We suggest that the
mechanism by which -A2 binds to nucleic acids involves its strong
interaction with phosphodiester bonds via its positively charged
Lys, with the Trp residue stacking between the nucleotide base or ri-
bose in each strand of the nucleic acid duplex. Several AMPs are
known to exhibit nucleic acid binding properties [40,42]; these in-
clude cationic and hydrophobic-rich antimicrobial peptides, such as
indolicidin and LfcinB, as well as the scramble peptide PAF26
[24,43]. It can be reasonably expected that -A2 kills bacterial cells
by targeting DNA, RNA or proteins in order to inhibit synthesis
of nucleic acids and proteins. Notably, in contrast to some conven-
tional antibiotics, S. aureus remained susceptible to -A2, even after
prolonged exposure (Fig. 8).
The modes of action of HPA3NT3 and -A2 are summarized in Fig. 9.
HPA3NT3 exerts its bactericidal effects by intercalating into the mem-
brane, most likely through interaction between its Phe residues and
SM, and by inducing pore formation. In contrast, -A2 acts by penetrating
into the cytoplasm, binding to nucleic acids, and thus inhibiting protein
Fig. 9. The modes of action of HPA3NT3 and -A2. Schematic representation of the proposed mechanisms of action of HPA3NT3 and -A2 in bacterial cells.
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with rifampin. Collectively, these results suggest that -A2 could serve as
an effective antibiotic agent against multidrug-resistant bacterial
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